广泛性焦虑障碍与自主神经超敏及腹内侧前额叶皮层反应迟钝的关联:一项随机临床试验
这项交叉随机临床试验纳入58名女性(29例广泛性焦虑障碍患者与29名匹配健康对照),在双盲条件下随机静脉推注异丙肾上腺素(0.5和2.0 μg)与生理盐水,采用功能磁共振成像评估全脑血氧水平依赖反应。结果显示,在0.5 μg剂量异丙肾上腺素下,广泛性焦虑障碍组心率反应更高、心肺感觉强度评分更高、自报焦虑水平更高,且腹内侧前额叶皮层在峰值反应期和早期恢复期均出现显著低激活。腹内侧前额叶皮层低激活与心率及心跳、呼吸感觉强度呈负相关。
要点
- 0.5 μg异丙肾上腺素下,广泛性焦虑障碍组心率反应高于对照组(b=5.34;95%CI,2.06-8.61;P=.002)。
- 广泛性焦虑障碍组腹内侧前额叶皮层在峰值反应期(Cohen d=1.55;P<.001)和早期恢复期(Cohen d=1.52;P<.001)显著低激活。
- 腹内侧前额叶皮层低激活与心率(r56=-0.51,校正P=.001)及心跳、呼吸感觉强度呈负相关。
核心结论
- 在交叉随机临床试验中,广泛性焦虑障碍女性在低水平肾上腺素能刺激下表现出自主神经超敏,特征为心率升高、内感受觉察增强、焦虑增加以及腹内侧前额叶皮层神经反应迟钝。
- 作者认为这些发现支持自主神经过度唤醒可能与腹内侧前额叶皮层调节功能障碍有关的观点,该区域可能作为治疗靶点帮助广泛性焦虑障碍患者更适当地评估和调节交感唤醒信号。
研究设计与样本
- 采用交叉随机临床试验设计,于2017年1月1日至2019年11月31日在俄克拉何马州塔尔萨的Laureate脑研究所开展。
- 58名女性参与者纳入分析(具有无伪差数据),其中29例广泛性焦虑障碍患者(平均[SD]年龄26.9[6.8]岁),29名匹配健康对照(平均[SD]年龄24.4[5.0]岁)。
- 在双盲条件下,每人随机接受静脉推注异丙肾上腺素(0.5和2.0 μg)与生理盐水,各给药两次,采用功能磁共振成像评估全脑血氧水平依赖反应。
主要发现
- 在0.5 μg异丙肾上腺素剂量下,广泛性焦虑障碍组心率反应高于对照组(b=5.34;95%CI,2.06-8.61;P=.002)。
- 在0.5 μg异丙肾上腺素剂量下,广泛性焦虑障碍组心肺感觉强度评分高于对照组(b=8.38;95%CI,2.05-14.71;P=.01)。
- 在0.5 μg异丙肾上腺素剂量下,广泛性焦虑障碍组自报焦虑水平高于对照组(b=1.04;95%CI,0.33-1.76;P=.005)。
- 广泛性焦虑障碍组腹内侧前额叶皮层在峰值反应期(Cohen d=1.55;P<.001)和早期恢复期(Cohen d=1.52;P<.001)出现显著低激活。
- 在0.5 μg剂量下提取的信号变化百分比相关分析显示,腹内侧前额叶皮层低激活与心率(r56=-0.51,校正P=.001)、心跳感觉回顾强度(r56=-0.50,校正P=.002)和呼吸感觉回顾强度(r56=-0.44,校正P=.01)呈负相关;与连续刻度评分呈趋势水平负相关(r56=-0.38,校正P=.051);与焦虑(r56=-0.28,校正P=.27)和 chronotropic dose 25(r56=-0.14,校正P=.72)无此关联。
临床怎么用
- 原文结论指出,这些发现支持自主神经过度唤醒可能与腹内侧前额叶皮层调节功能障碍有关的观点,该区域可能作为治疗靶点帮助广泛性焦虑障碍患者更适当地评估和调节交感唤醒信号。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: β-Adrenergic stimulation elicits heart palpitations and dyspnea, key features of acute anxiety and sympathetic arousal, yet no neuroimaging studies have examined how the pharmacologic modulation of interoceptive signals is associated with fear-related neurocircuitry in individuals with generalized anxiety disorder (GAD). OBJECTIVE: To examine the neural circuitry underlying autonomic arousal induced via isoproterenol, a rapidly acting, peripheral β-adrenergic agonist akin to adrenaline. DESIGN, SETTING, AND PARTICIPANTS: This crossover randomized clinical trial of 58 women with artifact-free data was conducted from January 1, 2017, to November 31, 2019, at the Laureate Institute for Brain Research in Tulsa, Oklahoma. EXPOSURES: Functional magnetic resonance imaging was used to assess neural responses during randomized intravenous bolus infusions of isoproterenol (0.5 and 2.0 μg) and saline, each administered twice in a double-blind fashion. MAIN OUTCOMES AND MEASURES: Blood oxygen level-dependent responses across the whole brain during isoproterenol administration in patients with GAD vs healthy comparators. Cardiac and respiratory responses, as well as interoceptive awareness and anxiety, were also measured during the infusion protocol. RESULTS: Of the 58 female study participants, 29 had GAD (mean [SD] age, 26.9 [6.8] years) and 29 were matched healthy comparators (mean [SD] age, 24.4 [5.0] years). During the 0.5-μg dose of isoproterenol, the GAD group exhibited higher heart rate responses (b = 5.34; 95% CI, 2.06-8.61; P = .002), higher intensity ratings of cardiorespiratory sensations (b = 8.38; 95% CI, 2.05-14.71; P = .01), higher levels of self-reported anxiety (b = 1.04; 95% CI, 0.33-1.76; P = .005), and significant hypoactivation in the ventromedial prefrontal cortex (vmPFC) that was evident throughout peak response (Cohen d = 1.55; P < .001) and early recovery (Cohen d = 1.52; P < .001) periods. Correlational analysis of physiological and subjective indexes and percentage of signal change extracted during the 0.5-μg dose revealed that vmPFC hypoactivation was inversely correlated with heart rate (r56 = -0.51, adjusted P = .001) and retrospective intensity of both heartbeat (r56 = -0.50, adjusted P = .002) and breathing (r56 = -0.44, adjusted P = .01) sensations. Ventromedial prefrontal cortex hypoactivation correlated inversely with continuous dial ratings at a trend level (r56 = -0.38, adjusted P = .051), whereas anxiety (r56 = -0.28, adjusted P = .27) and chronotropic dose 25 (r56 = -0.14, adjusted P = .72) showed no such association. CONCLUSIONS AND RELEVANCE: In this crossover randomized clinical trial, women with GAD exhibited autonomic hypersensitivity during low levels of adrenergic stimulation characterized by elevated heart rate, heightened interoceptive awareness, increased anxiety, and a blunted neural response localized to the vmPFC. These findings support the notion that autonomic hyperarousal may be associated with regulatory dysfunctions in the vmPFC, which could serve as a treatment target to help patients with GAD more appropriately appraise and regulate signals of sympathetic arousal. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02615119.
引用
- Teed AR, Feinstein JS, Puhl M, et al. Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation: A Randomized Clinical Trial. JAMA Psychiatry. 2022. PMID: 35107563. doi:10.1001/jamapsychiatry.2021.4225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。